Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00027499
DRKS00027499
Recruiting
Not Applicable

Testing of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skin - FullSkin

niversitätsklinikum der RWTH Aachen0 sites40 target enrollmentFebruary 24, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsL10.0L12.0Pemphigus vulgarisBullous pemphigoid

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
L10.0
Sponsor
niversitätsklinikum der RWTH Aachen
Enrollment
40
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum der RWTH Aachen

Eligibility Criteria

Inclusion Criteria

  • •All adult male and female patients can participate in this research project,
  • •\- who are suspected of having a blistering autoimmune skin disease.
  • •\- understand the nature, significance and scope of the research project
  • •\- are able to understand and follow the instructions of the study personnel
  • •\- who have signed an informed consent form

Exclusion Criteria

  • •If one of the following criteria applies to the patient, he or she cannot participate in the research project
  • •\- Minority
  • •\- Pregnancy and breastfeeding
  • •\- lack of informed consent
  • •\- are incapable of giving consent and/or are unable to understand the nature, significance and scope of the research project and to give their consent in writing.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Evaluating a novel diagnostic test for the detection of Plasmodium infections at community level in The Gambia and Burkina FasoDiagnosis of Plasmodium infectionInfections and Infestations
ISRCTN15263932MRC Unit The Gambia at LSHTM1,900
Recruiting
Not Applicable
COVID-19 ANTibody And T-cell Assays
ACTRN12621000996864niversity of Otago3,000
Recruiting
Not Applicable
Development of non-invasive diagnostic test based on fetal DNA isolated from maternal blood (NATERA-study)chromosomal aberriationsgenetic defect10083624
NL-OMON37477eids Universitair Medisch Centrum300
Active, not recruiting
Phase 1
Validation of a test system for development of medications for alcoholism
EUCTR2015-002831-16-DETechnische Universität Dresden
Recruiting
Not Applicable
A study to determine the ability of a blood test for B-type Natriuretic Peptide signal peptide (BNP-SP) to act as an early indicator in Acute Coronary Syndrome (ACS)).
ACTRN12609000057280Health Research Council of New Zealand2,000